These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 26505148)

  • 1. Optimised transdermal delivery of pravastatin.
    Burger C; Gerber M; du Preez JL; du Plessis J
    Int J Pharm; 2015 Dec; 496(2):518-25. PubMed ID: 26505148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topical delivery of acyclovir and ketoconazole.
    Jacobs GA; Gerber M; Malan MM; du Preez JL; Fox LT; du Plessis J
    Drug Deliv; 2016; 23(2):631-41. PubMed ID: 25005585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative study on the topical and transdermal delivery of diclofenac incorporated in nano-emulsions, nano-emulgels, and a colloidal suspension.
    Louw EV; Liebenberg W; Willers C; Dube A; Aucamp ME; Gerber M
    Drug Deliv Transl Res; 2023 May; 13(5):1372-1389. PubMed ID: 36525200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of acyclovir cream and gel formulations for transdermal iontophoretic delivery.
    Siddoju S; Sachdeva V; Friden PM; Banga AK
    Ther Deliv; 2012 Mar; 3(3):327-38. PubMed ID: 22833993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Essential Fatty Acids as Transdermal Penetration Enhancers.
    van Zyl L; du Preez J; Gerber M; du Plessis J; Viljoen J
    J Pharm Sci; 2016 Jan; 105(1):188-93. PubMed ID: 26852854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design and development of insulin emulgel formulation for transdermal drug delivery and its evaluation.
    Akram M; Naqvi SB; Khan A
    Pak J Pharm Sci; 2013 Mar; 26(2):323-32. PubMed ID: 23455203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elimination of ketoprofen from the stratum corneum after topical administration with ketoprofen formulations in human subjects.
    Takeshi M; Ebihara T; Maekawa K; Yamamoto K; Higo N
    Int J Pharm; 2014 Apr; 465(1-2):197-201. PubMed ID: 24530385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting skin penetration of actives from complex cosmetic formulations: an evaluation of inter formulation and inter active effects during formulation optimization for transdermal delivery.
    Wiechers JW; Watkinson AC; Cross SE; Roberts MS
    Int J Cosmet Sci; 2012 Dec; 34(6):525-35. PubMed ID: 22950455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent expansions in an emergent novel drug delivery technology: Emulgel.
    Ajazuddin ; Alexander A; Khichariya A; Gupta S; Patel RJ; Giri TK; Tripathi DK
    J Control Release; 2013 Oct; 171(2):122-32. PubMed ID: 23831051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dermal delivery of desmopressin acetate using colloidal carrier systems.
    Getie M; Wohlrab J; Neubert RH
    J Pharm Pharmacol; 2005 Apr; 57(4):423-7. PubMed ID: 15831201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced transdermal delivery of diazepam by submicron emulsion (SME) creams.
    Schwarz JS; Weisspapir MR; Friedman DI
    Pharm Res; 1995 May; 12(5):687-92. PubMed ID: 7479554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of formulation on the in vitro transdermal penetration of flutrimazole.
    Ramis J; Conte L; Segado X; Forn J; Lauroba J; Calpena A; Escribano E; Domenech J
    Arzneimittelforschung; 1997 Oct; 47(10):1139-44. PubMed ID: 9368709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Penetration enhancing effects of selected natural oils utilized in topical dosage forms.
    Viljoen JM; Cowley A; du Preez J; Gerber M; du Plessis J
    Drug Dev Ind Pharm; 2015; 41(12):2045-54. PubMed ID: 26161938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative study on the bioequivalence of two formulations of pravastatin. Data from a crossover, randomised, open-label bioequivalence study in healthy volunteers.
    Almeida S; Filipe A; Almeida A; Gich I; Antonijoan R; Puntes M; Barbanoj M; Cruz Caturla M
    Arzneimittelforschung; 2006; 56(2):70-5. PubMed ID: 16572920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced Skin Deposition of Betamethasone Dipropionate from a Novel Formulation and Drug Delivery Technology.
    Draelos ZD; Draelos MM; Steele F; Georgiou M; Praestegaard M
    Dermatol Ther (Heidelb); 2023 Aug; 13(8):1763-1771. PubMed ID: 37351830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of an emulgel for the treatment of rosacea using quality by design approach.
    Torregrosa A; Ochoa-Andrade AT; Parente ME; Vidarte A; Guarinoni G; Savio E
    Drug Dev Ind Pharm; 2020 Feb; 46(2):296-308. PubMed ID: 31944126
    [No Abstract]   [Full Text] [Related]  

  • 17. Deposits from Creams Containing 20% (w/w) Urea and Suppression of Crystallization (Part 2): Novel Analytical Methods of Urea Accumulated in the Stratum Corneum by Tape stripping and Colorimetry.
    Goto N; Morita Y; Terada K
    Chem Pharm Bull (Tokyo); 2016; 64(8):1092-8. PubMed ID: 27477646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Derivatives of L-Ascorbic Acid in Emulgel: Development and Comprehensive Evaluation of the Topical Delivery System.
    Stolić Jovanović A; Martinović M; Žugić A; Nešić I; Tosti T; Blagojević S; Tadić VM
    Pharmaceutics; 2023 Mar; 15(3):. PubMed ID: 36986679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimization of chlorphenesin emulgel formulation.
    Mohamed MI
    AAPS J; 2004 Oct; 6(3):e26. PubMed ID: 15760111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Formulation and optimisation of Ozenoxacin topical nano-emulgel including a comprehensive methodology to qualify and validate the critical parameters of an
    Ramireddy AR; Behara DK
    Drug Dev Ind Pharm; 2024 Apr; 50(4):320-330. PubMed ID: 38459688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.